Viewing Study NCT00645151


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-04-12 @ 11:48 PM
Study NCT ID: NCT00645151
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2008-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dyslipidemias View
Keywords: